Searle Ambien
Executive Summary
The hypnotic agent is currently supported by a marketing network of 1,500 reps in the U.S., Searle said. The company also reported that Ambien has 54% of new prescriptions and 89% of sales in the hypnotic market. Figures reported by Searle's Ambien marketing partner Sanofi-Synthelabo in "The Pink Sheet" (Sept. 6, p. 14) were different from those of Searle's because of different market definitions